已发表的部分文献: 标题:Myc regulates the transcription of the PRC2 gene to control the expression of developmental genes in embryonic stem cells.作者:Neri F, Zippo A, Krepelova A, Cherubini A, Rocchigiani M, Oliviero S;杂志名称:Mol Cell Biol 标题:Alteration of histone H3K4 methylation in glomerular podocytes associated with proteinuria in patients with membranous nephropathy.作者:Fujino T, Hasebe N;杂志名称:BMC Nephrol 标题:Novel detection of post-translational modifications in human monocyte-derived dendritic cells after chronic alcohol exposure: Role of inflammation regulator H4K12ac.作者:Parira T, Figueroa G, Laverde A, Casteleiro G, Gomez Hernandez ME, Fernandez-Lima F, Agudelo M;杂志名称:Sci Rep 标题:The role of RIPK1 mediated cell death in acute on chronic liver failure.作者:Kondo T, Macdonald S, Engelmann C, Habtesion A, Macnaughtan J, Mehta G, Mookerjee RP, Davies N, Pavesi M, Moreau R, Angeli P, Arroyo V, Andreola F, Jalan R;杂志名称:Cell Death Dis Epigentek 公司是全球领先的表观遗传学相关研究的技术创新者和产品开发供应商。开发了超过700多个专利产品,为表观遗传学方面的研究和新药研发提供全面系统的解决方案,涵盖样品制备、DNA/RNA甲基化(5-mc, 5-hmc, 5-fc, m6A)/DNMT分析、ChIP、组蛋白甲基化/乙酰化/去乙酰化/磷酸化/SUMO-等领域,提供小分子抑制剂、蛋白质、抗体、以及分析试剂盒产品。